# OnCo record anchordx-aurora (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/anchordx-aurora/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "anchordx-aurora" ;
  schema:name "Aurora (AnchorDx)"@en ;
  schema:description "A methylation blood test for six common cancers announced by AnchorDx of Guangzhou in 2020 at a target cost of about $100; whether it reached the market could not be confirmed."@en ;
  schema:url <https://onco.cc/drugs/anchordx-aurora/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.1stoncology.com/blog/?p=46876>, <https://doi.org/10.62347/TPTQ3682> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection blood test in development (cell-free DNA methylation)" ;
  schema:alternateName "Aurora" ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cfdna-methylation-testing/> ;
  onco:companies <https://onco.cc/companies/anchordx/> .